Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tatiana N. Lupanova
Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-Egfr Affibody
Frontiers in Pharmacology
Pharmacology
Related publications
In Vivo and in Vitro Uptake of 111In, Delivered With the Affibody Molecule (ZEGFR:955)2, in EGFR Expressing Tumour Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets
Current Pharmaceutical Design
Drug Discovery
Pharmacology
Sulforaphane-Conjugated Carbon Dots: A Versatile Nanosystem for Targeted Imaging and Inhibition of EGFR-Overexpressing Cancer Cells
Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells Through Downregulation of Akt
Journal of Cancer
Oncology
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-Egfr and Anti-Met Therapies
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
EGFR Gene Copy Number Assessment From Areas With Highest EGFR Expression Predicts Response to Anti-Egfr Therapy in Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules
Current Drug Metabolism
Clinical Biochemistry
Pharmacology
The Functional Verification of EGFR-CAR T-Cells Targeted to Hypopharyngeal Squamous Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology